Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
EYEPOINT PHARMACEUTICALS, INC. (EYPT) had Return on Investments of -15.15% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$24.45M |
|
$-45.20M |
|
$0.81M |
|
$23.65M |
|
$73.29M |
|
$-48.84M |
|
$3.64M |
|
$-45.20M |
|
$-45.20M |
|
$-45.20M |
|
$-45.20M |
|
$-45.20M |
|
$-45.20M |
|
$-48.84M |
|
$-50.07M |
|
69.77M |
|
69.77M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$326.98M |
|
$8.04M |
|
$35.58M |
|
$362.56M |
|
$41.68M |
|
-- |
|
$22.49M |
|
$64.17M |
|
$298.40M |
|
$298.40M |
|
$298.40M |
|
68.81M |
|
| Cash Flow Statement Financials | |
$-53.12M |
|
$39.52M |
|
$-0.95M |
|
$99.85M |
|
$85.31M |
|
$-14.55M |
|
$7.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.71% |
|
-199.72% |
|
-199.72% |
|
-- |
|
-184.82% |
|
-184.82% |
|
$-53.40M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.38 |
|
55.32 |
|
1.63 |
|
-15.15% |
|
-15.15% |
|
-12.47% |
|
|
Return on Investments |
-15.15% |
$4.34 |
|
$-0.77 |
|
$-0.76 |
|